MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR

被引：0
|
作者：
Sanjib Chaudhary
Muthamil Iniyan Appadurai
Shailendra Kumar Maurya
Palanisamy Nallasamy
Saravanakumar Marimuthu
Ashu Shah
Pranita Atri
Chirravuri Venkata Ramakanth
Subodh M. Lele
Parthasarathy Seshacharyulu
Moorthy P. Ponnusamy
Mohd W. Nasser
Apar Kishor Ganti
Surinder K. Batra
Imayavaramban Lakshmanan
机构：
[1] University of Nebraska Medical Center,Department of Biochemistry and Molecular Biology
[2] University of Nebraska Medical Center,Department of Pathology and Microbiology
[3] University of Nebraska Medical Center,Eppley Institute for Research in Cancer and Allied Diseases
[4] University of Nebraska Medical Center,Division of Oncology
[5] University of Nebraska Medical Center,Hematology, Department of Internal Medicine, VA Nebraska Western Iowa Health Care System
来源：
Breast Cancer Research | / 25卷
关键词：
UC16; ELAVL1/HuR; cMyc; YBX-1; YB1; MMP1; MMP3; TNBC; Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
    Chaudhary, Sanjib
    Appadurai, Muthamil Iniyan
    Maurya, Shailendra Kumar
    Nallasamy, Palanisamy
    Marimuthu, Saravanakumar
    Shah, Ashu
    Atri, Pranita
    Ramakanth, Chirravuri Venkata
    Lele, Subodh M.
    Seshacharyulu, Parthasarathy
    Ponnusamy, Moorthy P.
    Nasser, Mohd W.
    Ganti, Apar Kishor
    Batra, Surinder K.
    Lakshmanan, Imayavaramban
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [2] The role of RNA-binding protein HuR in lung metastasis of triple-negative breast cancer
    Techasintana, Patsharaporn
    Gubin, Matthew Michael
    Magee, Joseph David
    Dahm, Garrett MacKenzie
    Atasoy, Ulus
    CANCER RESEARCH, 2011, 71
  • [3] Targeting the RNA-binding protein HuR to overcome chemoresistance in triple-negative breast cancer
    Wei, Lanjing
    Zhang, Qi
    Gardashova, Gulhumay
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny R.
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2021, 81 (04)
  • [4] Overcome chemoresistance of triple-negative breast cancer by inhibiting the RNA-binding protein HuR
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny R.
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2022, 82 (04)
  • [5] Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    He, Lily
    Zhang, Yuxia
    Armaly, Ahlam M. M.
    Aube, Jeffrey
    Welch, Danny R. R.
    Xu, Liang
    Wu, Xiaoqing
    MOLECULAR ONCOLOGY, 2023, 17 (10) : 1962 - 1980
  • [6] Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Targeting the RNA-binding protein HuR to overcome chemoresistance in triple-negative breast cancer.
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny R.
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2021, 81 (13)
  • [8] The RNA-binding protein HuR/Elavl1 controls a core gene regulatory circuitry essential for MPNST growth and metastasis
    Tamayo Caro, M.
    Palomo Irigoyen, M.
    Perez Andres, E.
    Iruarrizaga Lejarreta, M.
    Varela Rey, M.
    Woodhoo, A.
    GLIA, 2019, 67 : E719 - E719
  • [9] The RNA-Binding Protein Elavl1/HuR Is Essential for Placental Branching Morphogenesis and Embryonic Development
    Katsanou, Vicky
    Milatos, Stavros
    Yiakouvaki, Anthie
    Sgantzis, Nikos
    Kotsoni, Anastasia
    Alexiou, Maria
    Harokopos, Vaggelis
    Aidinis, Vassilis
    Hemberger, Myriam
    Kontoyiannis, Dimitris L.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (10) : 2762 - 2776
  • [10] Functional inhibition of RNA-binding protein HuR reverses chemotherapeutic resistance in triple-negative breast cancer
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny R.
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2022, 82 (12)
12345